Pursuant to the terms of the agreement, the two companies will develop and market new products based on Bio-Rad’s surface-enhanced laser desorption/ionization (SELDI) technology in combination with Bruker’s matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF/TOF) mass spectrometers for applications of high-throughput protein profiling and identification.
The products will provide new solutions for biomarker discovery, in particular, the detection and high-confidence identification of intact peptides and proteins under 30 kilodaltons, which are known to be challenging for currently available technologies to identify, the two companies said.
Gary Kruppa, vice president for business development at Bruker Daltonics, said: “Bruker Daltonics’s high-performance TOF/TOF technology will bring a new dimension to protein profiling and identification, expanding the capabilities of Bio-Rad’s established SELDI technology.
“New products based on this combination of technologies will allow access to new technical capabilities and new market segments in applied proteomics, enabling researchers to better identify and characterize new biomarkers.”